Medical Device Industry Latest News Report (Updated April 15, 2026)

Domestic News

1. Fujifilm Launches New Version of CT System "SCENARIA View Plus"

【New Product/Technological Innovation】
Fujifilm Medical Co., Ltd. announced that it will begin offering a new version of its 64-row, 128-slice multi-slice CT system "SCENARIA View Plus" starting June 1, 2026. This product is newly equipped with "DLR Focus," an image noise reduction processing technology developed using AI technology (Deep Learning), achieving further reduction in radiation exposure. Additionally, the application range of the motion correction technology "StillShot" has been expanded to include the head and abdomen, in addition to the chest and heart.

Impact on the Industry: Amidst the increasing medical needs due to an aging population and the demand for rapid diagnosis by limited personnel in emergency medical settings, the automation of workflows and improvement of image quality utilizing AI are expected to significantly contribute to reducing the burden on medical professionals and improving the quality of diagnosis.

2. International Technical Exhibition of Medical Imaging "ITEM2026" to be Held at Pacifico Yokohama

【Event/Industry Trend】
The International Technical Exhibition of Medical Imaging "ITEM2026," Japan's largest medical imaging equipment exhibition organized by the Japan Radiological Society, will be held at Pacifico Yokohama from April 17 to 19, 2026. This exhibition will be held in a hybrid format (on-site exhibition and web exhibition), and over 150 companies are expected to showcase their latest medical devices, diagnostic imaging equipment, and AI-related systems.

Impact on the Industry: This event serves as a platform where various companies will collectively unveil their latest AI solutions and next-generation modalities (MRI, CT, etc.), making it a crucial milestone for predicting future technological trends and the development directions of each company in the field of diagnostic imaging.

3. IMDRF Publishes Draft Framework for Best Practices in AI Utilization in Medical Devices

【Regulatory Trends】
The International Medical Device Regulators Forum (IMDRF) has announced the release of a draft “Technical Framework for Artificial Intelligence Life Cycle Management” aimed at mitigating risks throughout the product lifecycle of medical devices incorporating artificial intelligence (AI), and has commenced soliciting public comments.

Impact on the Industry: The formulation of international guidelines by the IMDRF, in which Japan participates, is a highly significant development that will promote the standardization of global development and approval processes for AI medical devices, and facilitate compliance with regulatory requirements in various countries.

International News

4. Avanos Medical Agrees to Approximately $1.3 Billion Acquisition by Private Equity Firm AIP

【M&A and Business Strategy】
Avanos Medical, a company specializing in pain management and digestive care products, announced that it has agreed to be acquired by an affiliate of the private equity (PE) firm American Industrial Partners (AIP). The transaction is valued at approximately $1.272 billion (all cash), with shareholders receiving $25 per share. This represents a premium of approximately 72% over the recent stock price.

Impact on the Industry: Following Hologic's recent privatization (acquisition by Blackstone and TPG), this is a symbolic example indicating the increasing activity of large-scale M&A by private equity in the MedTech industry.

5. Johnson & Johnson Announces Q1 2026 Results, MedTech Division Performs Strongly

【Financial Performance and Market Trends】
Johnson & Johnson announced its first-quarter 2026 results, with sales increasing by 9.9% year-over-year to $24.1 billion. Notably, the MedTech (medical devices) division performed strongly, with sales reaching $8.4 billion (up 7.7% year-over-year). Growth was driven by electrophysiology products such as the Varipulse pulsed field ablation (PFA) platform, Abiomed's heart pumps, and Shockwave's intravascular lithotripsy devices. In response, the company has raised its full-year 2026 earnings outlook.

Impact on the Industry: This indicates that strategic investments and new product launches in the cardiovascular field (especially arrhythmia treatment and structural heart disease) are steadily yielding results, and market competition in this area is expected to intensify further.

6. Latest Funding and FDA Approval Trends in the Global MedTech Industry

【Regulatory Trends and Funding】
In the global MedTech market, over 10 FDA-related milestones (approvals, clearances, breakthrough designations, etc.) and 6 funding rounds (totaling approximately $235 million) were reported in the past week.

• Allevion Medical: Received FDA clearance for its Vantage system, which supports minimally invasive spinal surgery.
• Endospan: Received FDA approval for its NEXUS Aortic Arch Stent Graft System for treating complex aortic arch lesions.
• E2 (Endovascular Engineering): Completed an $80 million Series C funding round for the commercialization of its Hēlo Thrombectomy System for pulmonary embolism treatment.

Impact on the Industry: Investments and product commercialization in minimally invasive treatment devices and AI/robotics-driven solutions are rapidly advancing in the neurovascular, cardiovascular, and orthopedic (spine) fields.

References

• FUJIFILM Medical: New version of multi-slice CT system "SCENARIA View Plus" launched
• Eizo Joho Medical: "ITEM in JRC Exhibition Guide" released - International Medical Imaging Exhibition ITEM2026 -
• GMP Platform: IMDRF / Announces draft framework for best practices in AI utilization in medical devices
• MassDevice: Avanos Medical agrees to be acquired by private equity firm in $1.3B deal
• MassDevice: Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%
• GS Capital Connect: GS MedTech Weekly Roundup - Week 15, 2026